CL2008002758A1 - Composition comprising at least one laxative active principle and at least one antifoam active principle; use for the treatment of constipation. - Google Patents

Composition comprising at least one laxative active principle and at least one antifoam active principle; use for the treatment of constipation.

Info

Publication number
CL2008002758A1
CL2008002758A1 CL2008002758A CL2008002758A CL2008002758A1 CL 2008002758 A1 CL2008002758 A1 CL 2008002758A1 CL 2008002758 A CL2008002758 A CL 2008002758A CL 2008002758 A CL2008002758 A CL 2008002758A CL 2008002758 A1 CL2008002758 A1 CL 2008002758A1
Authority
CL
Chile
Prior art keywords
active principle
constipation
treatment
laxative
composition
Prior art date
Application number
CL2008002758A
Other languages
Spanish (es)
Inventor
Marianne Petersen-Braun Dr
Ulrike Weingartner Dr
Havertz Brigitte
Schnier Thomas
Original Assignee
Bayer Consumer Care Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40044033&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CL2008002758(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bayer Consumer Care Ag filed Critical Bayer Consumer Care Ag
Publication of CL2008002758A1 publication Critical patent/CL2008002758A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4402—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 2, e.g. pheniramine, bisacodyl
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/80—Polymers containing hetero atoms not provided for in groups A61K31/755 - A61K31/795
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/482—Cassia, e.g. golden shower tree
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10—Laxatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Composición farmacéutica que comprende un principio activo laxante y un principio activo antiespumante; y su uso en el tratamiento del estreñimiento, reducción o eliminación de la aparición de flatulencia o urgencia súbita y dolorosa de defecar.Pharmaceutical composition comprising a laxative active principle and an antifoam active principle; and its use in the treatment of constipation, reduction or elimination of the appearance of flatulence or sudden and painful urge to defecate.

CL2008002758A 2007-09-22 2008-09-16 Composition comprising at least one laxative active principle and at least one antifoam active principle; use for the treatment of constipation. CL2008002758A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP07018665 2007-09-22

Publications (1)

Publication Number Publication Date
CL2008002758A1 true CL2008002758A1 (en) 2009-08-14

Family

ID=40044033

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2008002758A CL2008002758A1 (en) 2007-09-22 2008-09-16 Composition comprising at least one laxative active principle and at least one antifoam active principle; use for the treatment of constipation.

Country Status (7)

Country Link
AR (1) AR068530A1 (en)
CL (1) CL2008002758A1 (en)
DE (1) DE112008002398A5 (en)
PE (1) PE20091192A1 (en)
TW (1) TW200930385A (en)
UY (1) UY31343A1 (en)
WO (1) WO2009036906A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008503445A (en) * 2004-04-13 2008-02-07 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング Use of simethicone in patients with constipation
GB0913295D0 (en) 2009-07-30 2009-09-02 Norgine Bv Improvements in and relating to pharmaceutical compositions
DE102012024434A1 (en) 2012-12-14 2014-06-18 Regalismons S.A. Enhancement of the defoaming action of polysiloxanes, related compositions and solutions
EP2898893A1 (en) * 2014-01-23 2015-07-29 Miklos Varhalmi Improved cholagogue compositions for treating biliary and digestive tract discomfort
CN107787223A (en) * 2015-06-22 2018-03-09 西梯茜生命工学股份有限公司 Cleaning intestinal tract purgatives composition
IT201700108033A1 (en) 2017-09-27 2019-03-27 Neilos S R L Composition for the treatment of constipation
EP3572068A1 (en) 2018-05-22 2019-11-27 RECORDATI INDUSTRIA CHIMICA E FARMACEUTICA S.p.a. New salt of cysteamine for the preparation of highly respirable particles

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7767203B2 (en) * 1998-08-07 2010-08-03 Ganeden Biotech, Inc. Methods for the dietary management of irritable bowel syndrome and carbohydrate malabsorption
CN1288730A (en) * 1999-09-07 2001-03-28 麦克内尔-Ppc股份有限公司 Slight-purgitive composition
JP2008503445A (en) * 2004-04-13 2008-02-07 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング Use of simethicone in patients with constipation

Also Published As

Publication number Publication date
DE112008002398A5 (en) 2010-07-29
PE20091192A1 (en) 2009-08-02
UY31343A1 (en) 2009-03-31
AR068530A1 (en) 2009-11-18
WO2009036906A1 (en) 2009-03-26
TW200930385A (en) 2009-07-16

Similar Documents

Publication Publication Date Title
CL2008000442A1 (en) PHARMACEUTICAL COMPOSITION THAT INCLUDES A CHITOSAN, A COSMETIC OR PHARMACEUTICAL ACTIVE INGREDIENT, AND A VOLATILE SOLVENT; AND ITS USE TO TREAT PSORIASIS, MICOSIS BETWEEN OTHER DISEASES.
CL2008001268A1 (en) Compounds derived from n- [6-amino-5-aryl-pyridin-2-yl] -carboxamide; pharmaceutical composition that includes them; combined pharmaceutical composition comprising them together with another additional pharmacological agent; and use them in the treatment of pain.
UY29086A1 (en) NEW PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF HYPERPROLIFERATIVE DISORDERS.
CL2008002758A1 (en) Composition comprising at least one laxative active principle and at least one antifoam active principle; use for the treatment of constipation.
CL2013003455A1 (en) Use of benzene-derived sglt-2 inhibitor compounds substituted by glucopyranosyl to prevent, slow progression, delay or treat a metabolic disorder in a patient with a neuroleptic agent; use of the combination of the sglt2 inhibitor with a neuroleptic; and pharmaceutical composition of the combination.
CL2013001433A1 (en) Composition comprising at least one n-acetyl lactosamine, at least one sialylated oligosaccharide at least one fucosylated oligosaccharide; and its use in the prevention of acute respiratory infections and / or to relieve the symptoms of said infections.
AR054227A1 (en) COMPOSITION OF ACTIVE PRINCIPLES
AR051969A1 (en) METHODS AND COMPOSITIONS THAT USE IMMUNOMODULATING COMPOUNDS FOR THE TREATMENT AND MANAGEMENT OF INJURIES OF THE CENTRAL NERVOUS SYSTEM
AR077199A1 (en) PHARMACEUTICAL COMPOSITION AND TREATMENT PROCEDURE FOR EMERGENCY ANTI-CONCEPTION
CL2011003350A1 (en) Nitrogenous heterocycle derivative compounds, pkm2 modulators; pharmaceutical composition comprising them; and its use in the treatment of cancer.
UY31673A1 (en) "UREA HETEROCYCLIC DERIVATIVES AND METHODS OF USE OF THE SAME-211"
CL2008001983A1 (en) COMPOUNDS DERIVED FROM FTALAZINONA; PHARMACEUTICAL COMPOSITION THAT INCLUDES SUCH COMPOUNDS; AND ITS USE TO TREAT VASCULAR DISEASES, SEPTIC SHOCK, ISCHEMICAL INJURIES, NEUROTOXICITY, HEMORRAGICAL SHOCK, VIRAL INFECTIONS, AMONG OTHERS.
CL2007002635A1 (en) Quinazolinone and isoquinolinone derived compounds, modulators of hpa axis activity; pharmaceutical composition comprising them; and its use in the treatment and / or prevention related to stress or depression.
CR11723A (en) AGENT TO TREAT DISEASE
AR047928A1 (en) TETRAHYDROPIRIDOINDOL DERIVATIVES
CO6321225A2 (en) SOLID CARRIER PARTICLES TO IMPROVE THE PROCESSABILITY OF A PHARMACEUTICAL AGENT
CL2008002381A1 (en) Immunostimulatory oligonucleotide; pharmaceutical composition comprising it; and its use to treat a disorder or condition in a subject, including cancer.
CR20110596A (en) SUBLINGUAL COMPOSITIONS OF DEXMEDETOMIDINE AND METHODS OF USE OF THEM
BRPI0806531A2 (en) COMPOUND, PHARMACEUTICAL COMPOSITION, THERAPEUTIC AGENT, AND USE OF THE COMPOUND.
CL2008002984A1 (en) Pharmaceutical composition comprising mycophenolate sodium and its use for the treatment and / or prevention of autoimmune diseases such as rejection of allografts or xenografts of organs, cells or tissues and as an anti-inflammatory.
ECSP10010589A (en) PHARMACO AGAINST LIVER CANCER
AR066312A1 (en) USE OF MUCINE GLUCOPROTEINS IN COMBINATION WITH THERAPEUTIC AGENTS TO TREAT EPITELIAL INJURIES AND DISORDERS DUE TO THE FUNCTION OF THE MUCINE
CL2007003356A1 (en) COMPOUNDS DERIVED FROM BENZOPIRAZOLES; PROCESS FOR THE PREPARATION OF SUCH COMPOUNDS; PHARMACEUTICAL COMPOSITION THAT INCLUDES SUCH COMPOUNDS AND ANOTHER ACTIVE AGENT; AND ITS USE FOR THE TREATMENT OF ASTHMA, INFLAMMATION, AMONG OTHER DISEASES.
AR072685A1 (en) TOPICAL COMPOSITION FOR THE TREATMENT OF ACTINIC KERATOSIS
CL2011003327A1 (en) Pharmaceutical composition comprising finafloxacin and an anti-inflammatory agent; use in the treatment of ophthalmic, otic or nasal infections.